Back
ESC2025 Premium Access

Therapeutic potential of pxl065 (deuterium-stabilized r-enantiomer of pioglitazone) in hypertrophic cardiomyopathy

Session: Molecular networks and emerging therapeutics in cardiac pathophysiology
Topic: Cardiomyopathies
Speaker: Ms A. Pfaller (Munich, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Ms Anna-Theresa Pfaller

German Heart Center of Munich, Munich (Germany)
0 follower

6 more presentations in this session

Early life stress Induces age-dependent cardiac dysfunction in exposed parents and in their offspring

Speaker: Doctor S. Mohammed (Zurich, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

mRNA therapeutics encoding multiple cardiac-reparative factors using polyplex nanomicelle attenuating myocardial infarction

Speaker: Doctor K. Handa (Suita, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

miR-125b-5p and miR-125b-1-3p mediate TGF-beta response in ischemic heart failure

Speaker: Mr I. Hagerstrom (Helsingfors, FI)

Access
Abstract
Slides
Video
Like
Thumbnail

Prime editing correction of an Nkx2-5 variant in a murine congenital heart disease model

Speaker: Mr D. Nishijo (Tokyo, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

NRF2/beta3-adrenoreceptor signaling drives a sustained antioxidant and metabolic rewiring through the pentose-phosphate pathway to alleviate cardiac stress

Speaker: Professor J. Balligand (Brussels, BE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Molecular networks and emerging therapeutics in cardiac pathophysiology

Speakers: Ms A. Pfaller, Doctor S. Mohammed, Doctor K. Handa, Mr I. Hagerstrom, Mr D. Nishijo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources